-
Taxonomy & unit
-
us-gaap: CAD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Evome Medical Technologies Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q1 2021 to Q4 2023.
- Evome Medical Technologies Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending December 31, 2023 was CA$7.8M, a 22.8% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (CAD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)